The Patent Finder
US

Therapeutic Formulation for Reduced Drug Side Effects

US 10,912,744 In force
OverviewFamilyAssignmentsSources & methods

Term ends Apr 25, 2031 · High confidence

Filed Sep 23, 2019 as application 16/579,054 · Granted Feb 9, 2021
Base term, 20 years from filing
Today
20 years from filing
2011 2031
Clock starts
Apr 25, 2011
Term ends
Apr 25, 2031
Granted
Feb 9, 2021
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 25, 2011, when application 13/093,662, the earliest non-provisional in its chain, was filed (this one was filed Sep 23, 2019)Apr 25, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderApr 25, 2031High confidence

This family

US 10,463,633In force
Apr 2031
Apr 2031
US 9,511,037In force
Apr 2031
Apr 2031
US 10,912,744this patent
Apr 2031
Apr 2031
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 23, 2020
Reel 53863, frame 360
Genco Sciences LLC,Kempharm, Inc.Assignment of Assignor's Interest
Oct 6, 2020
Reel 53985, frame 770
Genco Sciences LLCKempharm, Inc.Corrective Assignment to Correct the Execution Date of Assignor, Genco Sciences LLC, Incorrectly Recorded as 09-27-2017 Previously Recorded at Reel: 053863 Frame: 0360. Assignor(S) Hereby Confirms the Assognment.
Feb 23, 2024
Reel 66664, frame 108
Kempharm, Inc.Zevra Therapeutics, Inc.Change of Name
Apr 8, 2024
Reel 67040, frame 637
Zevra Therapeutics, Inc.Alter Domus (US) LLCSecurity Interest
Mar 13, 2026
Reel 75080, frame 907
Alter Domus (US) LLCZevra Therapeutics, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited